Indiana University Health
- Type
- Teaching hospital
- Where
- Indianapolis, IN
- Medicare CCN
- 150056
- Received
- $4,286,305 in 96 records, 2022 ($3,764,503 general, $521,802 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: Indiana University Health, Inc. Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Nonprofit contractor: INDIANA UNIVERSITY HEALTH Fuzzy (name and state)
- Federal award recipient: INDIANA UNIVERSITY HEALTH INC Fuzzy (name and state)
- Federal award recipient: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Lobbying client: INDIANA UNIVERSITY HEALTH INC Fuzzy (name and state)
- Lobbying client: INDIANA UNIVERSITY HEALTH INC Fuzzy (name and state)
- Lobbying client: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Lobbying client: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Lobbying registrant: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Nonprofit: INDIANA UNIVERSITY HEALTH INC Fuzzy (name and state)
- Patent assignee: Indiana University Health, Inc. Fuzzy (name and state)
- Trademark owner: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2022 | General payment | 42 | $3,764,503 |
| 2022 | Research payment | 54 | $521,802 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Cook Medical LLC | 2 | $3,533,871 | 2022 |
| Gyrus ACMI, Inc. | 6 | $103,611 | 2022 |
| Medtronic, Inc. | 17 | $101,949 | 2022 |
| Gilead Sciences, Inc. | 1 | $99,000 | 2022 |
| Siemens Medical Solutions USA, Inc. | 1 | $77,044 | 2022 |
| Novartis Pharmaceuticals Corporation | 1 | $61,266 | 2022 |
| Merck Sharp & Dohme LLC | 4 | $56,630 | 2022 |
| National Marrow Donor Program | 4 | $35,115 | 2022 |
| Roche Products Limited | 7 | $32,715 | 2022 |
| AngioDynamics, Inc. | 2 | $29,500 | 2022 |
| Janssen Research & Development, LLC | 4 | $28,356 | 2022 |
| Stryker Corporation | 2 | $26,010 | 2022 |
| Medical Device Business Services, Inc. | 8 | $24,400 | 2022 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $17,000 | 2022 |
| E.R. Squibb & Sons, L.L.C. | 3 | $15,851 | 2022 |
| Celgene Corporation | 1 | $13,350 | 2022 |
| AtriCure, Inc. | 1 | $8,051 | 2022 |
| KARL STORZ Endoscopy-America | 1 | $4,968 | 2022 |
| Boston Scientific Corporation | 3 | $4,018 | 2022 |
| Amryt Pharma Holdings Ltd | 4 | $3,869 | 2022 |
| Creo Medical Inc. | 1 | $3,568 | 2022 |
| Abbott Laboratories | 2 | $2,129 | 2022 |
| Cook Research Incorporated | 1 | $2,000 | 2022 |
| Cochlear Americas | 10 | $1,173 | 2022 |
| ConvaTec Inc. | 1 | $500 | 2022 |
| Hikma Pharmaceuticals USA | 4 | $232 | 2022 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $122 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Grant | 3 | $3,632,871 |
| Research payment | 54 | $521,802 |
| Space rental or facility fees (teaching hospital only) | 15 | $50,468 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 4 | $35,115 |
| Long term medical supply or device loan | 2 | $29,500 |
| Education | 1 | $8,051 |
| Debt forgiveness | 12 | $6,264 |
| Consulting Fee | 1 | $2,000 |
| Food and Beverage | 4 | $232 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | Gilead Sciences, Inc. | $99,000 | Grant | Cash or cash equivalent | 2022 | ||
| 2022-12-31 | Siemens Medical Solutions USA, Inc. | $77,044 | Research payment | In-kind items and services | Biograph mCT X-4R Device, MI - Nuclear Medicine (incl. PETNET & MIBR) | 68Ga PSMA PET and TBDE CT in preprostatectomy patients | 2022 |
| 2022-12-31 | Merck Sharp & Dohme LLC | $54,655 | Research payment | Cash or cash equivalent | Biological, CARDIOVASCULAR | A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for | 2022 |
| 2022-12-31 | AngioDynamics, Inc. | $28,500 | Long term medical supply or device loan | In-kind items and services | NanoKnife Device, Oncology Surgery | 2022 | |
| 2022-12-31 | KARL STORZ Endoscopy-America | $4,968 | Debt forgiveness | In-kind items and services | 2022 | ||
| 2022-12-31 | AngioDynamics, Inc. | $1,000 | Long term medical supply or device loan | In-kind items and services | Navigator Bionavigation System Device, Vascular Access | 2022 | |
| 2022-12-31 | Merck Sharp & Dohme LLC | $502 | Research payment | In-kind items and services | Biological, CARDIOVASCULAR | A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for | 2022 |
| 2022-12-31 | Merck Sharp & Dohme LLC | $27 | Research payment | In-kind items and services | Biological, CARDIOVASCULAR | A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for | 2022 |
| 2022-12-23 | Medical Device Business Services, Inc. | $6,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CARTO 3 Device, Cardiology | 2022 | |
| 2022-12-23 | Medical Device Business Services, Inc. | $3,800 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CARTO 3 Device, Cardiology | 2022 | |
| 2022-12-23 | Medical Device Business Services, Inc. | $2,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CARTO 3 Device, Cardiology | 2022 | |
| 2022-12-16 | Takeda Pharmaceuticals U.S.A., Inc. | $10,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2022 | ||
| 2022-12-08 | Medtronic, Inc. | $6,085 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-12-08 | Medtronic, Inc. | $132 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-12-02 | Janssen Research & Development, LLC | $1,199 | Research payment | Cash or cash equivalent | A Phase 3 Prospective Multi Center Double blind Double dummy Randomized Active controlled Parallel Group sequential Adap | 2022 | |
| 2022-11-30 | Creo Medical Inc. | $3,568 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SPEEDBOAT Device, Gastroenterology | 2022 | |
| 2022-11-28 | Roche Products Limited | $6,762 | Research payment | Cash or cash equivalent | Esbriet Biological, Immunology | TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM 151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS | 2022 |
| 2022-11-14 | Medtronic, Inc. | $13,958 | Research payment | Cash or cash equivalent | ACTIVA PC Device, Deep Brain Neurostimulation | PSR-DBS | 2022 |
| 2022-11-04 | E.R. Squibb & Sons, L.L.C. | $12,639 | Research payment | Cash or cash equivalent | A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes | 2022 | |
| 2022-11-03 | Janssen Research & Development, LLC | $3,778 | Research payment | Cash or cash equivalent | A Phase 3 Prospective Multi Center Double blind Double dummy Randomized Active controlled Parallel Group sequential Adap | 2022 | |
| 2022-10-27 | Gyrus ACMI, Inc. | $16,672 | Research payment | Cash or cash equivalent | EVIS EXERA lll COLONOVIDEOSCOPE Device, Gastroenterology | Evaluation of the Clinical Performance of an Investigational Real-Time Colorectal Polyp Clinical Decision Support Device | 2022 |
| 2022-10-26 | Takeda Pharmaceuticals U.S.A., Inc. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2022 | ||
| 2022-10-21 | National Marrow Donor Program | $8,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-10-20 | Merck Sharp & Dohme LLC | $1,444 | Research payment | In-kind items and services | Biological, CARDIOVASCULAR | A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for | 2022 |
| 2022-09-29 | Amryt Pharma Holdings Ltd | $1,319 | Research payment | Cash or cash equivalent | MYCAPSSA Drug, Endocrinology | MACRO Registry | 2022 |
| 2022-09-28 | C. R. Bard, Inc. & Subsidiaries | $122 | Debt forgiveness | In-kind items and services | 2022 | ||
| 2022-09-22 | Stryker Corporation | $5,202 | Research payment | Cash or cash equivalent | AN EXTERNAL FEMALE URINARY COLLECTION DEVICE: A PROSPECTIVE, DESCRIPTIVE STUDY | 2022 | |
| 2022-09-22 | Roche Products Limited | $1,600 | Research payment | Cash or cash equivalent | Drug | EFFECTS OF RO7486967 IN COPD | 2022 |
| 2022-09-20 | Boston Scientific Corporation | $692 | Research payment | Cash or cash equivalent | WATCHMAN Access System Device, STRUCTURAL HEART | OPTION | 2022 |
| 2022-09-16 | Hikma Pharmaceuticals USA | $132 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-09-13 | Medical Device Business Services, Inc. | $3,800 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CARTO 3 Device, Cardiology | 2022 | |
| 2022-09-12 | Cook Medical LLC | $400,000 | Grant | Cash or cash equivalent | 2022 | ||
| 2022-09-07 | Medical Device Business Services, Inc. | $3,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CARTO 3 Device, Cardiology | 2022 | |
| 2022-09-07 | Medical Device Business Services, Inc. | $2,800 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CARTO 3 Device, Cardiology | 2022 | |
| 2022-09-07 | Medical Device Business Services, Inc. | $2,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CARTO 3 Device, Cardiology | 2022 | |
| 2022-09-07 | Medical Device Business Services, Inc. | $400 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CARTO 3 Device, Cardiology | 2022 | |
| 2022-09-06 | Medtronic, Inc. | $6,832 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-09-06 | Medtronic, Inc. | $52 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-08-31 | Gyrus ACMI, Inc. | $6,175 | Research payment | Cash or cash equivalent | EVIS EXERA lll COLONOVIDEOSCOPE Device, Gastroenterology | Evaluation of the Clinical Performance of an Investigational Real-Time Colorectal Polyp Clinical Decision Support Device | 2022 |
| 2022-08-12 | Janssen Research & Development, LLC | $18,899 | Research payment | Cash or cash equivalent | Macitentan in inoperable or persistent recurrent chronic thromboembolic pulmonary hypertension A prospective randomized | 2022 | |
| 2022-08-12 | Medtronic, Inc. | $11,546 | Research payment | Cash or cash equivalent | ACTIVA PC Device, Deep Brain Neurostimulation | PSR-DBS | 2022 |
| 2022-08-05 | National Marrow Donor Program | $11,085 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-08-03 | Gyrus ACMI, Inc. | $24,486 | Research payment | Cash or cash equivalent | EVIS EXERA lll COLONOVIDEOSCOPE Device, Gastroenterology | Evaluation of the Clinical Performance of an Investigational Real-Time Colorectal Polyp Clinical Decision Support Device | 2022 |
| 2022-08-03 | Gyrus ACMI, Inc. | $4,163 | Research payment | Cash or cash equivalent | EVIS EXERA lll COLONOVIDEOSCOPE Device, Gastroenterology | Evaluation of the Clinical Performance of an Investigational Real-Time Colorectal Polyp Clinical Decision Support Device | 2022 |
| 2022-08-01 | Amryt Pharma Holdings Ltd | $163 | Research payment | Cash or cash equivalent | MYCAPSSA Drug, Endocrinology | MACRO Registry | 2022 |
| 2022-07-21 | Amryt Pharma Holdings Ltd | $2,060 | Research payment | Cash or cash equivalent | MYCAPSSA Drug, Endocrinology | MACRO Registry | 2022 |
| 2022-07-21 | Amryt Pharma Holdings Ltd | $326 | Research payment | Cash or cash equivalent | MYCAPSSA Drug, Endocrinology | MACRO Registry | 2022 |
| 2022-07-20 | Hikma Pharmaceuticals USA | $26 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-07-19 | Janssen Research & Development, LLC | $4,480 | Research payment | Cash or cash equivalent | Uptravi Selexipag the users drug registry | 2022 | |
| 2022-07-19 | Cochlear Americas | $34 | Debt forgiveness | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-07-12 | Roche Products Limited | $15,200 | Research payment | Cash or cash equivalent | Drug | EFFECTS OF RO7486967 IN COPD | 2022 |
| 2022-07-12 | Roche Products Limited | $3,400 | Research payment | Cash or cash equivalent | Drug | EFFECTS OF RO7486967 IN COPD | 2022 |
| 2022-07-12 | Roche Products Limited | $2,850 | Research payment | Cash or cash equivalent | Drug | EFFECTS OF RO7486967 IN COPD | 2022 |
| 2022-07-12 | Roche Products Limited | $1,903 | Research payment | Cash or cash equivalent | Drug | EFFECTS OF RO7486967 IN COPD | 2022 |
| 2022-07-12 | Roche Products Limited | $1,000 | Research payment | Cash or cash equivalent | Drug | EFFECTS OF RO7486967 IN COPD | 2022 |
| 2022-06-27 | Cochlear Americas | $63 | Debt forgiveness | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-06-27 | Cochlear Americas | $34 | Debt forgiveness | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-06-21 | Boston Scientific Corporation | $2,339 | Research payment | Cash or cash equivalent | WATCHMAN Access System Device, STRUCTURAL HEART | OPTION | 2022 |
| 2022-06-13 | AtriCure, Inc. | $8,051 | Education | Cash or cash equivalent | ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM Device, CARDIOVASCULAR | 2022 | |
| 2022-06-10 | ConvaTec Inc. | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | FLEXI-SEAL PROTECT FMS Device, CRITICAL CARE | 2022 | |
| 2022-06-06 | Medtronic, Inc. | $4,512 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-06-06 | Medtronic, Inc. | $105 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-06-06 | Medtronic, Inc. | $52 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-05-18 | Medtronic, Inc. | $7,661 | Research payment | Cash or cash equivalent | ACTIVA PC Device, Deep Brain Neurostimulation | PSR-DBS | 2022 |
| 2022-05-09 | Takeda Pharmaceuticals U.S.A., Inc. | $3,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2022 | ||
| 2022-05-09 | Takeda Pharmaceuticals U.S.A., Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2022 | ||
| 2022-05-06 | Cook Medical LLC | $3,133,871 | Grant | Cash or cash equivalent | 2022 | ||
| 2022-04-29 | National Marrow Donor Program | $7,770 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-04-27 | Cochlear Americas | $594 | Debt forgiveness | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-04-27 | Cochlear Americas | $171 | Debt forgiveness | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-04-27 | Cochlear Americas | $136 | Debt forgiveness | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-04-27 | Cochlear Americas | $68 | Debt forgiveness | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-04-27 | Cochlear Americas | $34 | Debt forgiveness | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-04-20 | Novartis Pharmaceuticals Corporation | $61,266 | Research payment | Cash or cash equivalent | LEQVIO Drug, CARDIOVASCULAR | A RANDOMIZED, MULTICENTER, OPEN-LABEL TRIAL COMPARING THE EFFECTIVENESS OF AN INCLISIRAN FIRST IMPLEMENTATION STRATEGY T | 2022 |
| 2022-04-18 | E.R. Squibb & Sons, L.L.C. | $12 | Research payment | Cash or cash equivalent | Phase II/III Long Term Roll Over IBD - An Open-label, Multi-center Extension Study to Evaluate the Long-term Safety and | 2022 | |
| 2022-04-14 | Hikma Pharmaceuticals USA | $20 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-04-13 | Gyrus ACMI, Inc. | $16,672 | Research payment | Cash or cash equivalent | EVIS EXERA lll COLONOVIDEOSCOPE Device, Gastroenterology | Evaluation of the Clinical Performance of an Investigational Real-Time Colorectal Polyp Clinical Decision Support Device | 2022 |
| 2022-03-31 | Abbott Laboratories | $2,030 | Research payment | Cash or cash equivalent | AGILIS HISPRO Device, Electrophysiology | Physiologic Pacing Registry | 2022 |
| 2022-03-22 | Celgene Corporation | $13,350 | Research payment | Cash or cash equivalent | Expanded Access Protocol (EAP) for Patients Receiving Idecabtagene Vicleucel (ide-cel) that is Non-conforming for Commer | 2022 | |
| 2022-03-21 | Boston Scientific Corporation | $987 | Research payment | Cash or cash equivalent | WATCHMAN Access System Device, STRUCTURAL HEART | OPTION | 2022 |
| 2022-03-17 | Medtronic, Inc. | $4,895 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-03-17 | Medtronic, Inc. | $105 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-03-17 | Medtronic, Inc. | $105 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-03-17 | Medtronic, Inc. | $52 | Research payment | Cash or cash equivalent | MICRA Device, Pacemakers | PSR-CVG | 2022 |
| 2022-03-15 | Cook Research Incorporated | $2,000 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-03-11 | Medtronic, Inc. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2022 | ||
| 2022-03-11 | Cochlear Americas | $34 | Debt forgiveness | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-03-09 | E.R. Squibb & Sons, L.L.C. | $3,200 | Research payment | Cash or cash equivalent | OPDIVO Biological, Oncology | Phase I/II Study of Nivolumab, Ipilimumab & Plinabulin in Patients with Recurrent Small Cell Lung Ca | 2022 |
| 2022-03-02 | Gyrus ACMI, Inc. | $35,441 | Research payment | Cash or cash equivalent | EVIS EXERA lll COLONOVIDEOSCOPE Device, Gastroenterology | Evaluation of the Clinical Performance of an Investigational Real-Time Colorectal Polyp Clinical Decision Support Device | 2022 |
| 2022-02-25 | Cochlear Americas | $2 | Debt forgiveness | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-02-14 | Medtronic, Inc. | $10,090 | Research payment | Cash or cash equivalent | ACTIVA PC Device, Deep Brain Neurostimulation | PSR-DBS | 2022 |
| 2022-02-03 | Stryker Corporation | $20,808 | Research payment | Cash or cash equivalent | AN EXTERNAL FEMALE URINARY COLLECTION DEVICE: A PROSPECTIVE, DESCRIPTIVE STUDY | 2022 | |
| 2022-01-28 | National Marrow Donor Program | $7,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-01-24 | Medtronic, Inc. | $30,766 | Research payment | In-kind items and services | MINIMED 670G Device, Durable Pump | CEP304 HCL Outcomes Study | 2022 |
| 2022-01-21 | Abbott Laboratories | $99 | Research payment | In-kind items and services | I-STAT Device, Point of Care | Clinical Evaluation of the i-STAT TBI Test | 2022 |
| 2022-01-19 | Hikma Pharmaceuticals USA | $53 | Food and Beverage | In-kind items and services | 2022 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Indianapolis city, IN, county Marion County, IN, state Indiana; placed by its city name.
| Measure | Place (city or town) Indianapolis city, IN | County Marion County, IN | State Indiana |
|---|---|---|---|
| Population B01003 | 885,860 | 975,809 | 6,851,073 |
| Population, 2020 census P1 | 887,642 | 977,203 | 6,785,528 |
| Median age B01002 | 34.3 | 34.4 | 38.1 |
| Under 18 B01001 | 24.8% | 25.0% | 23.3% |
| 65 and over B01001 | 13.1% | 13.2% | 16.8% |
| Households B11001 | 362,961 | 400,432 | 2,716,009 |
| Foreign born B05002 | 12.7% | 12.6% | 6.3% |
| Median household income B19013 | $66,219 | $66,346 | $71,957 |
| Median family income B19113 | $82,766 | $83,024 | $90,767 |
| Per capita income B19301 | $37,680 | $37,704 | $38,351 |
| Poverty rate B17001 | 15.8% | 15.3% | 12.3% |
| Unemployment rate B23025 | 5.1% | 5.0% | 4.3% |
| Civilian labor force B23025 | 472,847 | 520,799 | 3,472,016 |
| Mean commute (minutes) B08013 | 24.6 | 24.5 | 24.1 |
| Bachelor's degree or higher B15003 | 34.9% | 34.8% | 29.5% |
| Housing units B25001 | 401,428 | 441,040 | 2,976,568 |
| Owner-occupied B25003 | 56.0% | 56.5% | 70.6% |
| Renters B25003 | 44.0% | 43.5% | 29.4% |
| Median home value B25077 | $224,800 | $224,000 | $218,200 |
| Median gross rent B25064 | $1,156 | $1,153 | $1,062 |
| White, not Hispanic B03002 | 48.9% | 49.5% | 75.4% |
| Black B03002 | 27.6% | 27.1% | 9.1% |
| Hispanic or Latino B03002 | 13.8% | 13.8% | 8.6% |
| Asian B03002 | 4.2% | 4.0% | 2.6% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Economy now FRED unemployment 3.4% in Sep 2026 (3.7% a year earlier); per capita personal income $66,455 in 2025, up 28% in five years (+3.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Indianapolis city, IN.
Comments